HRT Financial’s Oric Pharmaceuticals ORIC Stock Holding History

HRT Financial’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66M	Buy	+153,245	New	+$1.39M	﹤0.01%	1849
2025 Q3	–	Sell	-102,583	Closed	-$1.04M	–	3446
2025 Q2	$1.04M	Buy	+102,583	New	+$689K	﹤0.01%	1251
2023 Q2	–	Sell	-126,147	Closed	-$719K	–	3032
2023 Q1	$719K	Buy	+126,147	New	+$659K	0.01%	1146
2022 Q2	–	Sell	-46,446	Closed	-$248K	–	3511
2022 Q1	$248K	Buy	+46,446	New	+$418K	﹤0.01%	2369
2021 Q2	–	Sell	-49,514	Closed	-$1.21M	–	3336
2021 Q1	$1.21M	Buy	+49,514	New	+$1.56M	0.01%	953

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's ORIC Position: Q2 2026 in Review

HRT Financial opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 153,245 shares worth $1.66M. The stake represents ﹤0.01% of the portfolio and ranks #1849 among its holdings. This is a return to the name: HRT Financial previously reported a position in ORIC as recently as Q2 2025.

HRT Financial first reported a position in ORIC in Q1 2021 and has held it in 5 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

HRT Financial held 153,245 shares of Oric Pharmaceuticals worth $1.66M as of Q2 2026.
Oric Pharmaceuticals was a new HRT Financial position in Q2 2026.
Oric Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1849 holding.
HRT Financial first reported a position in Oric Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.